10.1152/ajpregu.00128.2019 79 PriyadarshiniM.LaydenB
Dehydration is a potential complication that can occur in people using GLP-1 receptor agonist injections, such as semaglutide (Wegovy) and tirzepatide (Mounjaro), for weight management or diabetes control
Whether you're seeking hydration, nutrient replenishment, or recovery support, our team is here to help
Over time, GeneDx plans to expand into newborn screening, a potentially $10 billion marketthen eventually into adult screening to replace multi-gene panel and individual gene tests, a future market pegged at $16 billion, Katherine Stueland, GeneDxs president and CEO, told GEN Edge last month With tougher comps in 25 and a potential headwind to revenues emerging in HCT, it is harder to argue for multiple expansion from here, Peterson said